SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on June 1, 2016. The report discloses a material corporate event occurring on the same date. Note: The request metadata references "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as "Second Sight Medical Products, Inc."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves solely to announce a capital event and incorporates a press release by reference.
Material Changes
On June 1, 2016, the company announced the completion of an oversubscribed rights offering. This event represents a material change in the company's capital structure, though specific financial terms (such as total proceeds or share count) are not detailed within the body of this 8-K text.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or a discussion of risks and contingencies. It strictly reports the completion of the rights offering and references the associated press release (Exhibit 99.1) for further details.
Investor Verification Checklist
- Verify the exact terms of the rights offering (price per share, total shares issued, and total capital raised) in the referenced press release (Exhibit 99.1).
- Confirm the dilution impact on existing shareholders resulting from the oversubscribed offering.
- Review the company's use of proceeds as outlined in the press release.
- Check subsequent filings for updated financial statements reflecting the new capital.